Physical Therapy vs Arthroscopic Partial Meniscectomy

March 11, 2023 updated by: Shenzhen People's Hospital

Physical Therapy vs Arthroscopic Partial Meniscectomy on the Knee Function of Metabolic Syndrome Patients With Degenerative Meniscus Lesions

The purpose was to assess knee function outcomes between physical therapy and arthroscopic partial menisectomy(APM) for Metabolic syndrome(MetS) patients with degenerative meniscus lesions(DMLs) during 12 month follow up.

Study Overview

Detailed Description

Metabolic syndrome were diagnosed with abdominal obesity, insulin resistance with or without glucose intolerance, dyslipidemia or elevated blood pressure and widely prevalence all around the world.MetS patients were always correlated with knee osteoarthritis or cartilage volume loss. For MetS patients with DMLs, whether physical therapy was non-inferior to APM in knee function and MetS components was unknown.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Shenzhen, Guangdong, China, 121000
        • Recruiting
        • ShenZhen People's Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Must be age between 35 and 70 years old;

    • Clinical diagnosis of metabolic syndrome;
    • Clinical diagnosis of degenerative meniscus lesions;
    • Patients who has knee pain history
    • Knee symptoms consistent with DMLs verified on MRI
    • eligible for arthroscopic partial meniscectomy surgery by the examining orthopedic surgeons.

Exclusion Criteria:

  • Must be able to have no acute knee injury such as car crash or acute sports injury;

    • Must be able to have no knee surgeries history;
    • Must be able to have no rheumatoid arthritis or serious knee osteoarthritis with deformity;
    • Must be able to have no contraindications to MRI;
    • Must be able to have no severe cardiopulmonary disease;
    • Must be able to have no musculoskeletal or neuromuscular impairments ;
    • Must be able to have good visual, hearing, or cognitive;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: physical therapy
Physical therapy mainly include aerobic exercises and resistance exercise, flexibility exercises about 150 minutes for ≥2 d/week for 6 months.
The exercise intervention included aerobic exercises and resistance exercise, flexibility exercises about 150 minutes for ≥2 day per week.
Active Comparator: arthroscopic partial meniscectomy
The torn meniscus and unstable part were removed with arthroscopic instruments.
Arthroscopic partial meniscectomy surgery procedure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the Knee Injury and Osteoarthritis Outcome Score (KOOS) change
Time Frame: change from baseline up to 12 months
The Knee injury and Osteoarthritis Outcome Score (KOOS) holds five subscales including: Pain (9 items); other Symptoms (7 items); Activities of Daily Living (ADL, 17 items); Sport and Recreation function (Sport/Rec, 5 items); and knee-related Quality of Life (QoL, 4 items). Each subscale is scored separately from zero (extreme knee problems) to 100 (no knee problems)
change from baseline up to 12 months
the International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC Score) change
Time Frame: change from baseline up to 12 months
The International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC) score questionnaire contains 18 items (7 items for symptoms, 1 item for sport activity, 9 items for daily activities, and 1 item for current knee function.) The total score is transformed to a value on a scale of 0 to 100, with 100 representing the highest knee function and 0 is the worst.
change from baseline up to 12 months
waist circumstance change
Time Frame: change from baseline up to 12 months
waist circumstance (cm)
change from baseline up to 12 months
systolic blood pressure change
Time Frame: change from baseline up to 12 months
systolic blood pressure /mmHg
change from baseline up to 12 months
diastolic blood pressure change
Time Frame: change from baseline up to 12 months
diastolic blood pressure/mmHg
change from baseline up to 12 months
serum total cholesterol (TC) change
Time Frame: change from baseline up to 12 months
serum total cholesterol (TC) (mmol/L)
change from baseline up to 12 months
serum triglycerides (TG) change
Time Frame: change from baseline up to 12 months
serum triglycerides (TG) (mmol/L)
change from baseline up to 12 months
low-density lipoprotein cholesterol (LDL-C) change
Time Frame: change from baseline up to 12 months
serum low-density lipoprotein cholesterol (LDL-C) (mmol/L)
change from baseline up to 12 months
high-density lipoprotein cholesterol (HDL-C) change
Time Frame: change from baseline up to 12 months
serum high-density lipoprotein cholesterol (HDL-C) (mmol/L)
change from baseline up to 12 months
fast blood glucose(FBG) change
Time Frame: change from baseline up to 12 months
serum fast blood glucose(FBG) (mmol/L)
change from baseline up to 12 months
Body mass index change
Time Frame: change from baseline up to 12 months
Body mass index(BMI) weight/height square (kg/㎡)
change from baseline up to 12 months
Kellgren-Lawrence (K/L) grade change
Time Frame: change from baseline up to 12 months
Kellgren-Lawrence (K/L) grade
change from baseline up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain score change
Time Frame: change from baseline up to 12 months
The minimum is 0 points, the maximum is 4 points, from extreme knee problems to no knee problems. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
change from baseline up to 12 months
symptoms score change
Time Frame: change from baseline up to 12 months
The minimum is 0 points, the maximum is 4 points, from extreme knee problems to no knee problems. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula.
change from baseline up to 12 months
activities of daily living score change
Time Frame: change from baseline up to 12 months
The minimum is 0 points, the maximum is 4 points, from extreme knee problems to no knee problems. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula
change from baseline up to 12 months
function in sport and recreation score change
Time Frame: change from baseline up to 12 months
The minimum is 0 points, the maximum is 4 points, from extreme knee problems to no knee problems. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula
change from baseline up to 12 months
knee related quality of life score change
Time Frame: change from baseline up to 12 months
The minimum is 0 points, the maximum is 4 points, from extreme knee problems to no knee problems. After the score of each part is calculated separately, it is converted into a percentage score by the conversion formula
change from baseline up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2020

Primary Completion (Anticipated)

August 2, 2023

Study Completion (Anticipated)

August 10, 2023

Study Registration Dates

First Submitted

December 2, 2022

First Submitted That Met QC Criteria

December 16, 2022

First Posted (Actual)

December 19, 2022

Study Record Updates

Last Update Posted (Actual)

March 14, 2023

Last Update Submitted That Met QC Criteria

March 11, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ShenzhenPH meniscus001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Medial Meniscus Tears

Clinical Trials on physical therapy

3
Subscribe